JP2011527984A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527984A5 JP2011527984A5 JP2010549125A JP2010549125A JP2011527984A5 JP 2011527984 A5 JP2011527984 A5 JP 2011527984A5 JP 2010549125 A JP2010549125 A JP 2010549125A JP 2010549125 A JP2010549125 A JP 2010549125A JP 2011527984 A5 JP2011527984 A5 JP 2011527984A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- glucoside
- kaempferol
- quercetin
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 claims 3
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 claims 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims 3
- 208000019622 heart disease Diseases 0.000 claims 3
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 claims 3
- ZDQHCVFHPTWFMA-UHFFFAOYSA-N kaempferol 3-O-beta-D-glucoside Natural products OCC1OC(OC2=C(Oc3cc(O)cc(O)c3C2)c4ccc(O)c(O)c4)C(O)C(O)C1O ZDQHCVFHPTWFMA-UHFFFAOYSA-N 0.000 claims 3
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 claims 3
- FNTJVYCFNVUBOL-VFKUPZNOSA-N Kaempferol 3-glucuronide Natural products O=C(O)[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O)c3)C2=O)O1 FNTJVYCFNVUBOL-VFKUPZNOSA-N 0.000 claims 2
- DUBCCGAQYVUYEU-VFKUPZNOSA-N Miquelianin Natural products O=C(O)[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](OC2=C(c3cc(O)c(O)cc3)Oc3c(c(O)cc(O)c3)C2=O)O1 DUBCCGAQYVUYEU-VFKUPZNOSA-N 0.000 claims 2
- DUBCCGAQYVUYEU-UHFFFAOYSA-N Querciturone Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O DUBCCGAQYVUYEU-UHFFFAOYSA-N 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- FNTJVYCFNVUBOL-ZUGPOPFOSA-N kaempferol 3-O-glucuronide Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FNTJVYCFNVUBOL-ZUGPOPFOSA-N 0.000 claims 2
- DUBCCGAQYVUYEU-ZUGPOPFOSA-N miquelianin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O DUBCCGAQYVUYEU-ZUGPOPFOSA-N 0.000 claims 2
- 208000031225 myocardial ischemia Diseases 0.000 claims 2
- LOJXBHNAFUDMIQ-UHFFFAOYSA-N quercetin-3-alpha-glucuronide Natural products OC1OC(C(O)C(O)C1O)C(=O)Oc1c(oc2cc(O)cc(O)c2c1=O)-c1ccc(O)c(O)c1 LOJXBHNAFUDMIQ-UHFFFAOYSA-N 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 1
- 241001593968 Vitis palmata Species 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008012909.7 | 2008-03-06 | ||
| DE102008012909A DE102008012909A1 (de) | 2008-03-06 | 2008-03-06 | Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen |
| PCT/EP2009/052502 WO2009109573A1 (de) | 2008-03-06 | 2009-03-03 | Verwendung von flavonoidverbindungen für die propyhylaxe und therapie ischämischer oder entzündlicher herz- und kreislauferkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011527984A JP2011527984A (ja) | 2011-11-10 |
| JP2011527984A5 true JP2011527984A5 (https=) | 2012-04-26 |
Family
ID=40600026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010549125A Pending JP2011527984A (ja) | 2008-03-06 | 2009-03-03 | 虚血性又は炎症性の心疾患及び心臓血管疾患の予防と治療のためのフラボノイド化合物の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20110053874A1 (https=) |
| EP (1) | EP2268277A1 (https=) |
| JP (1) | JP2011527984A (https=) |
| CA (1) | CA2717012A1 (https=) |
| DE (1) | DE102008012909A1 (https=) |
| WO (1) | WO2009109573A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009027382A2 (de) * | 2007-08-31 | 2009-03-05 | Boehringer Ingelheim International Gmbh | Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub |
| DE102008012908A1 (de) * | 2008-03-06 | 2009-09-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten |
| BR112015008156A2 (pt) | 2012-10-11 | 2017-07-04 | Armaron Bio Pty Ltd | novos compostos flavonóides e suas respectivas utilizações |
| CN113398114B (zh) * | 2021-05-28 | 2022-11-01 | 浙江大学智能创新药物研究院 | 3,7,8,4′-四羟基黄酮在制备抗心血管疾病药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69918852T2 (de) * | 1998-10-29 | 2005-07-21 | Merck Patent Gmbh | Zusammensetzung enthaltend eine mischung von bioflavonoiden |
| JP2001122791A (ja) | 1999-10-20 | 2001-05-08 | Boehringer Ingelheim Internatl Gmbh | 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤 |
| CN1450905A (zh) * | 2000-05-25 | 2003-10-22 | 法马顿股份有限公司 | 增强细胞保护的方法 |
| CN1197567C (zh) * | 2002-10-21 | 2005-04-20 | 中国人民解放军第二军医大学 | 山奈酚衍生物用于制备防治脑血管疾病药物的用途 |
| AU2003298180B2 (en) | 2002-12-31 | 2010-01-21 | Boehringer Ingelheim International Gmbh | Film coated tablet comprising an extract of red vine leaves |
-
2008
- 2008-03-06 DE DE102008012909A patent/DE102008012909A1/de not_active Withdrawn
-
2009
- 2009-03-03 JP JP2010549125A patent/JP2011527984A/ja active Pending
- 2009-03-03 WO PCT/EP2009/052502 patent/WO2009109573A1/de not_active Ceased
- 2009-03-03 EP EP09718237A patent/EP2268277A1/de not_active Withdrawn
- 2009-03-03 CA CA2717012A patent/CA2717012A1/en not_active Abandoned
- 2009-03-03 US US12/919,561 patent/US20110053874A1/en not_active Abandoned
-
2012
- 2012-12-11 US US13/710,799 patent/US20130109641A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009537554A5 (https=) | ||
| JP2009524695A5 (https=) | ||
| RU2582676C3 (ru) | Некоторые химические соединения, композиции и способы | |
| JP2013513621A5 (https=) | ||
| EA201491060A1 (ru) | Новые производные трифторметилоксадиазола и их применение для лечения заболевания | |
| ME02307B (me) | Kristalni (r)-(e)-2-(4-(2-(5-(1-(3,5-diklorpiridin-4-il)etoksi)-1h-indazol- 3-il)vinil)-1h-pirazol-1-il)etanol i njegova upotreba kao inhibitora fgfr | |
| BR112012033715A2 (pt) | inibidores de quinase de regulação de sinal de apoptose. | |
| SI3150198T1 (sl) | Farmacevtski sestavki 3-(6-(1-(2,2-difluorobenzo(D)(1,3)dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il)benzojske kisline in dajanje le-teh | |
| JP2010504301A5 (https=) | ||
| CL2011000867A1 (es) | Formas cristalinas da, c y ii de (r)-5-[3-cloro-4-(2,3-dihidroxi-propoxi)- benz[z]ilideno]-2- ([z]- propilimino) -3-o- totil-tiazolidin-4-ona; composicion farmaceutica; y uso en el tratamiento o prevencion de rechazo de organos trasplantados, sindrome autoinmunitarios, asma, diabetes, cancer. | |
| AR075179A1 (es) | Formulaciones galenicas de compuestos organicos que comprenden alisquireno | |
| EA201300159A8 (ru) | Использование композиции salvia miltiorrhiza в приготовлении лекарственных препаратов для вторичной профилактики ишемической болезни сердца | |
| EA201071204A1 (ru) | Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности | |
| WO2011110939A3 (en) | Pharmaceutical compositions of substituted benzhydrylpiperazines | |
| PH12018500261B1 (en) | Azole benzene derivative | |
| HRP20171511T1 (hr) | Ivabradin-hidroklorid, oblik iv | |
| JP2015514797A5 (https=) | ||
| JP2011527984A5 (https=) | ||
| WO2011138265A3 (en) | Indole and indazole derivatives as orexin receptor antagonists | |
| WO2010006184A3 (en) | Small-molecule inhibitors of hif and angiogenesis | |
| JP2008266291A5 (https=) | ||
| EP2196463A4 (en) | PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, DERIVATIVES DERIVATED THEREOF AND PHARMACEUTICAL FORMULATIONS THEREOF | |
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| WO2010131192A3 (en) | Novel oxazolidinone derivatives and their use as orexin receptor antagonists | |
| JP2009505991A5 (https=) |